Telogen Effluvium and COVID-19: A Case and a Brief Review of Literature
November 2022
in “
Medicina
”
Studysummary This case report describes post-COVID-19 telogen effluvium in a 39-year-old patient, suggesting that COVID-19 may trigger significant hair loss as a late symptom.
Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer
Read the full study on revistas.usp.br →